A Clinical Perspective on Emerging Alzheimer’s Medications: Donanemab and Lecanemab
What Is Donanemab? Eli Lilly’s donanemab has recently gained attention as a potential breakthrough in Alzheimer’s drug treatment. This monoclonal antibody specifically targets a modified [...]